Biovie (BIVI) Preferred Dividend Payments (2018 - 2021)
Biovie (BIVI) posted Preferred Dividend Payments of $53.6 million for Q3 2021, little changed sequentially from $53.6 million in Q3 2020, and little changed YoY from $53.6 million in Q3 2020.
Biovie (BIVI) Preferred Dividend Payments (2018 - 2021) Analysis & Trends
Biovie has reported Preferred Dividend Payments for 4 years, with the latest figure at $53.6 million in Q3 2021.
- Quarterly Preferred Dividend Payments changed 0.0% year-over-year to $53.6 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $53.6 million (changed 0.0% YoY) and the FY2021 annual result came in at $53.6 million, up 213.46% from the prior year.
- Preferred Dividend Payments held at $53.6 million in Q3 2021 per BIVI's latest filing, from $53.6 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $53.6 million in Q3 2020 and troughed at $48659.0 in Q3 2018.
- A 4-year average of $31.1 million and a median of $35.3 million in 2019 frame the typical range for Preferred Dividend Payments.
- The sharpest annual moves came in 2019 and 2021: Preferred Dividend Payments jumped 35040.59% in 2019, then changed 0.0% in 2021.
- Over 4 years, Preferred Dividend Payments stood at $48659.0 in 2018, then surged by 35040.59% to $17.1 million in 2019, then surged by 213.46% to $53.6 million in 2020, then changed by 0.0% to $53.6 million in 2021.
- According to Business Quant data, Preferred Dividend Payments over the past three periods registered $53.6 million, $53.6 million, and $17.1 million for Q3 2021, Q3 2020, and Q3 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Biovie | 14.17 Mn | 14.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 53.60 Mn |
| Sep 30, 2020 | 53.60 Mn |
| Sep 30, 2019 | 17.10 Mn |
| Sep 30, 2018 | 48,659.00 |